Intra-Arterial Nimodipine for Severe Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Influence on Clinical Course and Cerebral Perfusion

References

1. ↵
   Findlay JM, Deagle GM. Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 1998;25:209–15

   PubMedWeb of Science
2. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1. Overall management results. J Neurosurg 1990;73:18–36

   PubMedWeb of Science
3. Kassell NF, Torner JC, Jane JA, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2. Surgical results. J Neurosurg 1990;73:37–47

   PubMedWeb of Science
4. ↵
   Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003;98:319–25

   PubMedWeb of Science
5. ↵
   Barker FG 2nd, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996;84:405–14

   PubMedWeb of Science
6. ↵
   Weyer GW, Nolan CP, Macdonald RL. Evidence-based cerebral vasospasm management. Neurosurg Focus 2006;21:E8

   PubMed
7. ↵
   Rinkel GJ, Feigin VL, Algra A, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005;25:CD000277
8. ↵
   Amin-Hanjani S, Ogilvy CS, Barker FG 2nd. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004;54:326–34, discussion 334–35

   PubMedWeb of Science
9. ↵
   Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330–36. Epub 2006 Dec 21

   Abstract/FREE Full Text
10. ↵
    Kasuya H, Onda H, Sasahara A, et al. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005;56:895–902

    PubMed
11. ↵
    Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001;48:249–61, discussion 261–62

    CrossRefPubMedWeb of Science
12. ↵
    Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994;25:1342–47

    Abstract/FREE Full Text
13. ↵
    Rinkel GJ, Feigin VL, Algra A, et al. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2004 :CD000483
14. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006;354:387–96

    CrossRefPubMedWeb of Science
15. ↵
    Treggiari MM, Walder B, Suter PM, et al. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98:978–84

    PubMedWeb of Science
16. ↵
    Dion JE, Duckwiler GR, Vinuela F, et al. Pre-operative micro-angioplasty of refractory vasospasm secondary to subarachnoid hemorrhage. Neuroradiology 1990;32:232–36

    CrossRefPubMed
17. ↵
    Kassell NF, Helm G, Simmons N, et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:848–52

    PubMedWeb of Science
18. ↵
    Biondi A, Ricciardi GK, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004;25:1067–76

    Abstract/FREE Full Text
19. ↵
    Rosenwasser RH, Armonda RA, Thomas JE, et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975–79, discussion 979–80

    PubMedWeb of Science
20. ↵
    Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284–90

    PubMedWeb of Science
21. ↵
    Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–84

    PubMedWeb of Science
22. ↵
    Polin RS, Hansen CA, German P, et al. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256–64; discussion 1264–67

    CrossRefPubMedWeb of Science
23. ↵
    Vajkoczy P, Horn P, Bauhuf C, et al. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 2001;32:498–505

    Abstract/FREE Full Text
24. ↵
    Boker DK, Solymosi L, Wassmann H. Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid hemorrhage with nimodipine: report on 3 cases. Neurochirurgia (Stuttg) 1985;28 (suppl 1):118–20

    PubMed
25. Bracard S, Arrue P, Barral FG, et al. Management of vasospasm from subarachnoid hemorrhage: attitude of French centers—French Society of Neuroradiology [in French]. J Neuroradiol 1999;26 (1 suppl):S44–47

    PubMed
26. ↵
    Grotenhuis JA, Bettag W, Fiebach BJ, et al. Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH: a preliminary report. J Neurosurg 1984;61:231–40

    PubMed
27. ↵
    Turowski B, Haenggi D, Wittsack HJ, et al. Computerized analysis of brain perfusion parameter images [lsqb]in German]. Rofo 2007;179:525–29

    PubMed
28. ↵
    Turowski B, Haenggi D, Wittsack J, et al. Cerebral perfusion computerized tomography in vasospasm after subarachnoid hemorrhage: diagnostic value of MTT [in German [. Rofo 2007;179:847–54

    PubMed
29. ↵
    Nabavi DG, LeBlanc LM, Baxter B, et al. Monitoring cerebral perfusion after subarachnoid hemorrhage using CT. Neuroradiology 2001;43:7–16

    CrossRefPubMed
30. ↵
    Wintermark M, Ko NU, Smith WS, et al. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol 2006;27:26–34

    Abstract/FREE Full Text
31. ↵
    Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049–60

    CrossRefPubMedWeb of Science
32. ↵
    Firat MM, Gelebek V, Orer HS, et al. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR Am J Neuroradiol 2005;26:1357–62

    Abstract/FREE Full Text
33. ↵
    Qureshi AI, Suarez JI, Bhardwaj A, et al. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2000;28:824–29

    CrossRefPubMed
34. ↵
    Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:819–26

    Abstract/FREE Full Text
35. ↵
    Feng L, Fitzsimmons BF, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 2002;23:1284–90

    Abstract/FREE Full Text
36. ↵
    Tejada JG, Taylor RA, Ugurel MS, et al. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 2007;28:844–48

    Abstract/FREE Full Text
37. ↵
    Dacquet C, Mironneau C, Mironneau J. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein. Br J Pharmacol 1987;92:203–11

    PubMedWeb of Science
38. ↵
    Schuknecht B, Fandino J, Yuksel C, et al. Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology 1999;41:453–62

    CrossRefPubMed
39. ↵
    Brauer P, Kochs E, Werner C, et al. Correlation of transcranial Doppler sonography mean flow velocity with cerebral blood flow in patients with intracranial pathology. J Neurosurg Anesthesiol 1998;10:80–85

    PubMedWeb of Science